Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.
Feifel D, Macdonald K, Nguyen A, Cobb P, Warlan H, Galangue B, Minassian A, Becker O, Cooper J, Perry W, Lefebvre M, Gonzales J, Hadley A.
Feifel D, et al. Among authors: macdonald k.
Biol Psychiatry. 2010 Oct 1;68(7):678-80. doi: 10.1016/j.biopsych.2010.04.039. Epub 2010 Jul 7.
Biol Psychiatry. 2010.
PMID: 20615494
Clinical Trial.